FFA
Fairfield Financial Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-61
| Closed | -$2.69K | – | 313 |
|
|
2023
Q1 | $2.69K | Sell |
61
-56
| -48% | -$2.47K | ﹤0.01% | 290 |
|
|
2022
Q4 | $4.76K | Hold |
117
| – | – | ﹤0.01% | 254 |
|
|
2022
Q3 | $7.65K | Hold |
117
| – | – | ﹤0.01% | 236 |
|
|
2022
Q2 | $7.11K | Hold |
117
| – | – | ﹤0.01% | 227 |
|
|
2022
Q1 | $7.34K | Buy |
+117
| New | +$7.34K | ﹤0.01% | 241 |
|